LU74411A1 - - Google Patents

Info

Publication number
LU74411A1
LU74411A1 LU74411A LU74411A LU74411A1 LU 74411 A1 LU74411 A1 LU 74411A1 LU 74411 A LU74411 A LU 74411A LU 74411 A LU74411 A LU 74411A LU 74411 A1 LU74411 A1 LU 74411A1
Authority
LU
Luxembourg
Application number
LU74411A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74411A1 publication Critical patent/LU74411A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
LU74411A 1975-02-24 1976-02-23 LU74411A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752508312 DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden

Publications (1)

Publication Number Publication Date
LU74411A1 true LU74411A1 (en:Method) 1976-08-13

Family

ID=5939872

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74411A LU74411A1 (en:Method) 1975-02-24 1976-02-23

Country Status (12)

Country Link
US (1) US4082911A (en:Method)
JP (1) JPS51125382A (en:Method)
BE (1) BE838879A (en:Method)
CA (1) CA1065315A (en:Method)
CH (1) CH626093A5 (en:Method)
DE (1) DE2508312A1 (en:Method)
DK (1) DK138900C (en:Method)
FR (1) FR2301536A1 (en:Method)
GB (1) GB1542442A (en:Method)
LU (1) LU74411A1 (en:Method)
NL (1) NL7601625A (en:Method)
SE (1) SE7602109L (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53108986A (en) * 1977-03-02 1978-09-22 Mitsui Toatsu Chem Inc Preparation of nucleosides and nucleotides
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
US4195176A (en) * 1977-10-11 1980-03-25 Warner-Lambert Company Imidazole compounds, methods for their production and conversion of said compounds into (R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
JPH029511U (en:Method) * 1988-06-21 1990-01-22
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
JPH07276137A (ja) * 1994-03-31 1995-10-24 Osaka Diamond Ind Co Ltd 切削・研削用工具
DE19513330A1 (de) * 1995-04-03 1996-10-10 Schering Ag Neues Verfahren zur Herstellung von Nucleosiden
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CN101099745A (zh) 2000-05-26 2008-01-09 艾登尼科斯(开曼)有限公司 处理黄病毒和瘟病毒的方法和组合物
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7662798B2 (en) 2002-06-28 2010-02-16 Idenix Pharmaceuticals, Inc. 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
DK1576138T3 (en) 2002-11-15 2017-05-01 Idenix Pharmaceuticals Llc 2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
US7038038B2 (en) * 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US6943249B2 (en) * 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
EP1620451A4 (en) 2003-04-28 2009-02-18 Novartis Ag TO THE MOST EXTENSIVE NUCLEOSIDE SYNTHESIS
RU2361875C2 (ru) 2003-06-30 2009-07-20 Айденикс (Кайман) Лимитед СИНТЕЗ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
AT502635A1 (de) * 2005-11-09 2007-05-15 Saischek Und Partner Meg Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung
EP1976382B1 (en) 2005-12-23 2013-04-24 IDENIX Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
RU2476207C2 (ru) 2008-05-15 2013-02-27 Селджин Корпорейшн Пероральные составы, содержащие аналоги цитидина, и способы их использования
EP2321302B1 (en) * 2008-08-01 2014-10-29 Dr. Reddy's Laboratories Ltd. Azacitidine process and polymorphs
US20100035354A1 (en) * 2008-08-06 2010-02-11 Ettore Bigatti Process for preparing azacytidine intermediate
CN102216315B (zh) * 2008-08-08 2016-06-29 台湾神隆股份有限公司 制备5-氮杂胞嘧啶核苷和其衍生物的方法
EP2424845A4 (en) * 2009-04-27 2014-03-05 Reddys Lab Ltd Dr PREPARATION OF DECITABIN
EP2691408B1 (en) 2011-03-31 2017-06-28 Celgene International SÁRL Synthesis of 5-azacytidine
CN108239128B (zh) * 2016-12-23 2019-03-29 江苏奥赛康药业股份有限公司 β-核苷类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354160A (en) * 1965-07-22 1967-11-21 Hoffmann La Roche Tri-lower alkyl-silyl-5-fluoropyrimidines
US3352849A (en) * 1965-10-24 1967-11-14 Merck & Co Inc 6-aza-2'-deoxyuridines
SU452961A3 (ru) * 1969-04-11 1974-12-05 Шеринг Аг. (Фирма) Способ получени пиримидиннуклеозидов
DE2122991C2 (de) * 1971-05-04 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden

Also Published As

Publication number Publication date
JPS51125382A (en) 1976-11-01
FR2301536A1 (fr) 1976-09-17
DK138900B (da) 1978-11-13
DE2508312A1 (de) 1976-09-02
GB1542442A (en) 1979-03-21
CA1065315A (en) 1979-10-30
DK77176A (da) 1976-08-25
FR2301536B1 (en:Method) 1979-07-27
US4082911A (en) 1978-04-04
JPS6139318B2 (en:Method) 1986-09-03
DE2508312C2 (en:Method) 1987-10-29
BE838879A (fr) 1976-08-24
DK138900C (da) 1979-04-30
NL7601625A (nl) 1976-08-26
SE7602109L (sv) 1976-08-25
CH626093A5 (en:Method) 1981-10-30

Similar Documents

Publication Publication Date Title
DK141381C (en:Method)
BG21774A1 (en:Method)
BG22169A1 (en:Method)
BG22346A1 (en:Method)
BG22361A1 (en:Method)
BG22957A1 (en:Method)
BG23030A1 (en:Method)
CH454375A4 (en:Method)
CH578718A5 (en:Method)
CH579839A5 (en:Method)
CH583936B5 (en:Method)
CH585102A5 (en:Method)
CH585980A5 (en:Method)
CH586413B5 (en:Method)
CH587128A5 (en:Method)
CH587706A5 (en:Method)
CH588407A5 (en:Method)
CH589528A5 (en:Method)
CH590733A5 (en:Method)
CH591010A5 (en:Method)
CH591181A5 (en:Method)
CH591651A5 (en:Method)
CH592466A5 (en:Method)
CH596636A5 (en:Method)
CH597193A5 (en:Method)